Immunovant

IMVT · NASDAQ

$28.59+$0.97 (+3.51%)TodayMarket closed ·
Prev close $27.62

Who owns IMVT

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 83.8% of IMVT’s shares.

  • Roivant Sciences Ltd.54.9%
  • Fidelity Management & Research Company LLC7.8%
  • Deep Track Capital LP4.5%
  • BlackRock Institutional Trust Company, N.A.3.0%
  • Next 6 largest institutions13.5%
  • All other shareholders16.2%
Top institutional holders of IMVT
HolderShares% of shares
Roivant Sciences Ltd.113.32M54.90%
Fidelity Management & Research Company LLC16.17M7.84%
Deep Track Capital LP9.34M4.53%
BlackRock Institutional Trust Company, N.A.6.24M3.02%
Farallon Capital Management, L.L.C.5.80M2.81%
Baker Bros. Advisors LP5.44M2.63%
State Street Investment Management (US)4.62M2.24%
TCG Crossover Management, LLC4.46M2.16%
Vanguard Portfolio Management, LLC3.91M1.89%
Vanguard Capital Management, LLC3.64M1.76%

Largest mutual fund holders

Top mutual fund holders of IMVT
HolderShares% of shares
Fidelity Growth Company Fund5.09M2.47%
State Street SPDR S&P Biotech ETF2.71M1.32%
Vanguard Total Stock Market Index Fund2.61M1.27%
iShares Russell 2000 ETF2.19M1.06%
Vanguard Small-Cap Index Fund1.89M0.91%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $13.60M (39 trades) of IMVT on the open market, with no buys.

Latest IMVT insider transactions
InsiderTypeSharesValue
Van Tuyl ChristopherSale1.33K$42.54K
Gloria MelanieSale2.24K$71.85K
Stout Jay SSale1.60K$51.17K
Stout Jay SSale2.21K$70.95K
Venker EricSale3.51K$119.59K
Venker EricOption exercise92.19K—
Venker EricOther85.89K$2.89M
Venker EricOption exercise92.19K$1.33M
Van Tuyl ChristopherSale2.85K$103.48K
Pande AtulOption exercise1.50K—

Short interest

Settled Sep 30, 2026

Shares short
17.42M
Days to cover
9.64
% of shares outstanding
8.44%
Average daily volume
1.81M
Change since last report
+0.9%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.